Antithymocyte Globulin and Lenalidomide
Antithymocyte globulin is a form of immunosuppressants that work by weakening the immune response of the body. People who get organ transplants often take these medications to prevent the new organ from being rejected. In those with myelodysplastic syndromes, the drug can help prevent further attacks from the immune system on stem cells in the bone marrow. This treatment option is suitable for those with a lower risk and have not had effective results with previous treatments. [3]
Lenalidomide is a form of immunomodulatory agents. These drugs work by improving the production of red blood cells in the bone marrow. A doctor tends to prescribe them when you have myelodysplastic syndromes and a genetic mutation called isolated del (5q) chromosome abnormality. Effects of lenalidomide can make patients less dependent on blood transfusions. Many scientists believe that the medication can be a good option for people with low or intermediate risk. There would be some possible side effects, such as constipation, diarrhea, or nausea. [4]
